Preferred Name |
obinutuzumab |
|
Synonyms |
RO-5072759 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C543332 |
|
altLabel |
RO-5072759 GA 101 GA101 antibody RO5072759 gazyvaro R7159 cpd RO 5072759 R 7159 R-7159 Immunoglobulin G1, anti-(human CD20 (antigen)) (human-mouse monoclonal GA101 heavy chain), disulfide with human-mouse monoclonal GA101 KAPPA-chain, dimer Gazyva GA-101 afutuzumab |
|
cui |
C2742503 C3692838 C2742506 C2742505 C2742504 |
|
HM |
D061067 |
|
II |
D018951 |
|
Inverse of RB |
O43472U9X8 0 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20090907 |
|
MeSH Frequency |
429 |
|
MMR |
20191031 |
|
notation |
C543332 |
|
PA |
D000074322 |
|
PI |
*ANTIBODIES, MONOCLONAL (2008-2011) |
|
prefLabel |
obinutuzumab |
|
SC |
1 |
|
Scope Statement |
anti-CD20 mAb for treating B-cell lymphoid cancers |
|
SRC |
Curr Opin Investig Drugs 2009 Jun;10(6):588-96 |
|
TERMUI |
T757414 T757415 T757408 T757417 T757410 T757412 T839365 T757413 T850630 T000967565 T757409 T757411 T757416 |
|
TH |
NLM (2009) NLM (2020) USAN (19XX) INN (19XX) NLM (2013) |
|
tui |
T109 T116 T129 T121 |
Create mapping